In a patient with ferritin 2200 µg/L and transferrin saturation 52 %, what diagnostic tests and treatment steps should be undertaken for suspected iron overload?

Diagnostic and Treatment Approach for Iron Overload with Ferritin 2200 µg/L and Transferrin Saturation 52%

This patient has biochemical evidence of iron overload requiring immediate HFE genetic testing for hereditary hemochromatosis, liver fibrosis assessment, and initiation of phlebotomy therapy if genetic testing confirms C282Y homozygosity. 1

Immediate Diagnostic Steps

1. Genetic Testing

Proceed directly to HFE genotyping for p.C282Y mutation - this patient meets the EASL 2022 criteria with transferrin saturation >50% and ferritin >300 µg/L (assuming male patient; >45% and >200 µg/L for females). 1 The 52% transferrin saturation is the critical discriminator indicating true iron overload rather than inflammatory hyperferritinemia. 2, 3

• Test specifically for p.C282Y homozygosity (most common cause of hereditary hemochromatosis)
• Consider p.H63D testing only if C282Y is negative and clinical suspicion remains high 1

2. Liver Fibrosis Assessment

Liver biopsy or non-invasive fibrosis assessment is mandatory because ferritin exceeds 1000 µg/L. 1, 4 The 2200 µg/L level places this patient at significant risk for advanced liver fibrosis.

Non-invasive options (perform first):

• Transient elastography: If liver stiffness <6.4 kPa, advanced fibrosis is ruled out 1
• FIB-4 score: Best validated serum marker, though evidence is limited specifically in hemochromatosis 1

Liver biopsy indications:

• If non-invasive tests suggest advanced fibrosis
• If liver enzymes are elevated
• To definitively assess cirrhosis presence 1

3. Hepatic Iron Quantification

Order liver MRI with R2-based iron quantification* to measure hepatic iron concentration and assess extrahepatic organ involvement. 1, 5 This is the preferred method with strongest evidence for accurate, reproducible quantification. 5

• Confounder-corrected R2*-based technique at 1.5T or 3T is the gold standard 5
• MRI quantifies iron in liver, spleen, pancreas, heart, and brain 1
• Cardiac MRI should be added if any signs of heart disease are present, given the severe iron overload level 1

4. Additional Baseline Laboratory Tests

Complete the differential diagnosis workup:

• Liver enzymes (AST, ALT, GGT)
• Complete blood count
• Glucose and HbA1c (diabetes screening)
• Lipid profile
• CRP to assess inflammatory component 2
• Serum iron and total iron binding capacity for additional diagnostic information 1

Do NOT measure hepcidin - this is not recommended per EASL guidelines. 1

5. Clinical Evaluation for Complications

Assess for extrahepatic manifestations that affect morbidity and quality of life:

• Endocrine: Diabetes, erectile dysfunction, loss of libido, amenorrhea
• Skeletal: Joint pain, arthritis, osteoporosis, fractures
• Cardiac: Heart failure symptoms, arrhythmias 1

Treatment Algorithm

If C282Y Homozygous (Most Likely Scenario)

Begin therapeutic phlebotomy immediately without waiting for MRI results. 2 This is the definitive treatment for hereditary hemochromatosis.

Phlebotomy protocol:

• Remove 450-500 mL blood weekly initially
• Target ferritin 50-100 µg/L
• Monitor ferritin and transferrin saturation every 3 months during de-ironing phase
• Once target reached, maintain with phlebotomy every 2-4 months

If Genetic Testing Negative or Compound Heterozygous

Do NOT start phlebotomy until MRI confirms significant hepatic iron overload. 2, 4 Management must be guided by phenotypic presentation, not genotype alone. 1

• If MRI shows hepatic iron concentration >120 µmol/g, consider phlebotomy with individualized assessment 4
• Investigate other causes: dysmetabolic iron overload syndrome (DIOS), alcohol-related hemosiderosis, rare genetic causes 2, 3, 4
• For DIOS: Address metabolic syndrome components; phlebotomy only in selected cases with significant hepatic iron on MRI 2, 4

If Advanced Fibrosis or Cirrhosis Detected

• Hepatocellular carcinoma surveillance with ultrasound ± AFP every 6 months
• Varices screening with upper endoscopy
• More aggressive iron removal may be needed
• Prognosis is normal if treatment started before cirrhosis develops 4

Critical Pitfalls to Avoid

1. Do not delay genetic testing - the transferrin saturation of 52% is diagnostic-level and demands immediate HFE genotyping 1

2. Do not start phlebotomy in non-C282Y homozygotes without MRI confirmation - you risk unnecessary treatment in dysmetabolic hyperferritinemia 2, 4

3. Do not ignore the ferritin >1000 µg/L threshold - this mandates fibrosis assessment regardless of other factors 1, 4

4. Do not overlook cardiac assessment - severe iron overload can cause life-threatening cardiomyopathy; cardiac MRI is indicated if any cardiac symptoms 1

5. Counsel about Vibrio vulnificus risk - patients with iron overload have >50% mortality from this infection; avoid raw seafood and warm coastal waters 1

6. Document any SGLT2 inhibitor or GLP-1 receptor agonist use - these medications alter ferritin interpretation 6

Family Screening

If C282Y homozygosity confirmed, test all first-degree adult relatives (>18 years) for the p.C282Y variant after obtaining informed consent. 1 This prevents morbidity and mortality in affected family members through early detection.